These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33439749)

  • 1. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults.
    Cirrincione LR; Winston McPherson G; Rongitsch J; Sadilkova K; Drees JC; Krasowski MD; Dickerson JA; Greene DN
    LGBT Health; 2021; 8(2):125-132. PubMed ID: 33439749
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women.
    Doll E; Gunsolus I; Thorgerson A; Tangpricha V; Lamberton N; Sarvaideo JL
    Endocr Pract; 2022 Mar; 28(3):237-242. PubMed ID: 34781041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Estrone in Feminizing Hormone Treatment.
    Tebbens M; Heijboer AC; T'Sjoen G; Bisschop PH; den Heijer M
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e458-e466. PubMed ID: 34632510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial.
    Cortez S; Moog D; Lewis C; Williams K; Herrick C; Fields M; Gray T; Guo Z; Nicol G; Baranski T
    JMIR Res Protoc; 2023 Dec; 12():e53092. PubMed ID: 38133914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Different Estradiol Regimens in Transgender Females: A Randomized Controlled Trial.
    Cortez S; Moog D; Lewis C; Williams K; Herrick CJ; Fields ME; Gray T; Guo Z; Nicol G; Baranski T
    J Endocr Soc; 2024 Jul; 8(8):bvae108. PubMed ID: 38962490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Distinct Antiandrogen Exposures on the Plasma Metabolome in Feminizing Gender-affirming Hormone Therapy.
    Shepherd R; Angus LM; Mansell T; Arman B; Kim BW; Lange K; Burgner D; Kerr JA; Pang K; Zajac JD; Saffery R; Cheung A; Novakovic B
    J Clin Endocrinol Metab; 2024 Oct; 109(11):2857-2871. PubMed ID: 38609170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels.
    Rothman MS; Ariel D; Kelley C; Hamnvik OR; Abramowitz J; Irwig MS; Soe K; Davidge-Pitts C; Misakian AL; Safer JD; Iwamoto SJ
    Endocr Pract; 2024 Sep; 30(9):870-878. PubMed ID: 38782202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
    Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
    BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
    Cirrincione LR; Narla RR
    J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.
    Torres-Santiago L; Mericq V; Taboada M; Unanue N; Klein KO; Singh R; Hossain J; Santen RJ; Ross JL; Mauras N
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2716-24. PubMed ID: 23678038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Hormone Concentrations in Transgender Youth Receiving Estradiol.
    Sumerwell C; Carlin K; Walsh E; Hodax JK
    Endocr Pract; 2024 Feb; 30(2):155-159. PubMed ID: 38029927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Subcutaneous and Intramuscular Estradiol Regimens as Part of Gender-Affirming Hormone Therapy.
    Herndon JS; Maheshwari AK; Nippoldt TB; Carlson SJ; Davidge-Pitts CJ; Chang AY
    Endocr Pract; 2023 May; 29(5):356-361. PubMed ID: 36868378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial.
    Burinkul S; Panyakhamlerd K; Suwan A; Tuntiviriyapun P; Wainipitapong S
    J Sex Med; 2021 Jul; 18(7):1299-1307. PubMed ID: 34274044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women.
    Haupt C; Henke M; Kutschmar A; Hauser B; Baldinger S; Saenz SR; Schreiber G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013138. PubMed ID: 33251587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.